|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 217/00 | |
| C07D 401/12 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07C 237/00 | |||
| A61P 27/00 | |||
| A61K 31/33 |
| (11) | Patento numeris | 2424842 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10709100.1 |
| Europos patento paraiškos padavimo data | 2010-01-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/022246 |
| Data | 2010-01-27 |
| (87) | Numeris | WO 2010/126626 |
| Data | 2010-11-04 |
| (30) | Numeris | Data | Šalis |
| 174672 P | 2009-05-01 | US |
| (72) |
DELONG, Mitchell, A., US
STURDIVANT, Jill, Marie, US
ROYALTY, Susan, M., US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
7020 Kit Creek Road, Suite 270 P. O. box 12320, Research Triangle Park, NC 27709,
US
|
| (54) | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |
| DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |